PATENT CLAIM ANALYSIS

Application Number: 15918169
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["424", "460000"]

Abstract:
A nasal delivery device for and method of delivering a substance, preferably comprising oxytocin, non-peptide agonists thereof and antagonists thereof, preferably as one of a liquid, as a suspension or solution, or a powder, to the nasal airway of a subject, preferably the posterior region of the nasal airway, and preferably the upper posterior region of the nasal airway which includes the olfactory bulb and the trigeminal nerve, and preferably in the treatment of neurological conditions and disorders.

Claim (Index 73):
The delivery device of  claim 71 , wherein the oxytocin is delivered as a powder.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 90.0
- Lexical Diversity: 1.95556
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14005363', '13180492', '10480582', '12281894', '15051622']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8253662318432695
- 35 USC 102 Novelty (BERT): 0.5748232375061172
- Combined Prediction Score: 0.8003119324095542
- Mean Citation Score: 473.862724
- Max Citation Score: 546.52814
- Similarity Product: 364.2819688913894

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test